There were no significant differences in hsCRP, insulin, C-peptide, triglycerides, or Cystatin C. HsCRP and Cystatin C have been associated with prediabetes28–30 and risk of developing type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.